Yacoub-Youssef H, Marcheix B, Calise D, Thiers J C, Benoist H, Blaes N, Ségui B, Dambrin C, Thomsen M
Inserm U466, and Laboratory for Microsurgery, CHU Rangueil, Toulouse, France.
Transplant Proc. 2005 Jan-Feb;37(1):75-6. doi: 10.1016/j.transproceed.2004.12.100.
We wanted to establish a preclinical model of chronic vascular rejection (CVR) by transplanting small arteries from the mesentery of cadaveric organ donors by the rapid "sleeve" technique into SCID/beige mice reconstituted with human allogeneic spleen cells. After institutional authorization and with informed consent from relatives, we obtained tissues and cells from cadaveric organ donors. A piece of mesentery was recovered from the donor and kept in buffered solution at 4 degrees C until use. After dissection of the mesentery, small arteries of suitable size were transplanted in place of the infrarenal aorta of the mice. Cells for the immunological reconstitution of the mice were spleen cells from the same or other organ donors. Twenty-three suitable arterial segments were obtained from the mesentery of three cadaveric donors. Ten of the mice received 3 x 10(7) human spleen cells intraperitoneally 1 week after the arterial graft and they all showed circulating human CD3+ and CD19+ cells 2 weeks after injection. The mice were sacrificed 5 weeks after the arterial graft. SCID/beige mice reconstituted with allogeneic spleen cells showed a typical CVR, whereas mice that received no cells had a normal vascular anatomy. We believe our model is well suited for the study of treatment of CVR under human allograft conditions.
我们希望通过快速“套入”技术将尸体器官供体肠系膜的小动脉移植到用人同种异体脾细胞重建的SCID/米色小鼠体内,建立慢性血管排斥反应(CVR)的临床前模型。经机构批准并获得亲属的知情同意后,我们从尸体器官供体获取组织和细胞。从供体处取出一片肠系膜,保存在4℃的缓冲溶液中备用。解剖肠系膜后,将合适大小的小动脉移植到小鼠肾下腹主动脉的位置。用于小鼠免疫重建的细胞是来自同一或其他器官供体的脾细胞。从三名尸体供体的肠系膜中获取了23个合适的动脉段。其中10只小鼠在动脉移植后1周腹腔内注射3×10⁷个人类脾细胞,注射后2周它们均显示循环中的人类CD3⁺和CD19⁺细胞。在动脉移植后5周处死小鼠。用同种异体脾细胞重建的SCID/米色小鼠表现出典型的CVR,而未接受细胞的小鼠血管解剖结构正常。我们认为我们的模型非常适合在人类同种异体移植条件下研究CVR的治疗。